Illumina to Webcast Upcoming Investor Conference Presentations
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast.
J.P. Morgan Healthcare Conference Presentation, San Francisco, CaliforniaMonday, January 8, 2018 at 3:30 pm Pacific Time
J.P. Morgan Healthcare Conference Question & Answer Session, San Francisco, CaliforniaMonday, January 8, 2018 at 4:00 pm Pacific Time
The webcasts can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171219005230/en/
Illumina, Inc.
Investors:
Jacquie Ross, CFA
858-882-2172
[email protected]
or
Media:
Eric
Endicott
858-882-6822
[email protected]
Source: Illumina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Illumina (ILMN) PT Raised to $200 at Piper Sandler
- TGE Highlights Significant Progress in Building Its Global AMTD-Branded Hotels Network
- Zentek's ZenGUARD(TM) Enhanced Air Filtration Media Completes Qualification Program with Quality Filters Inc.; First U.S. Commercial Order Received
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share